Search Results - "Arefieva, T I"

Refine Results
  1. 1

    Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium by Krasnikova, T. L., Arefieva, T. I., Pylaeva, E. A., Sidorova, M. V.

    “…Malignant gliomas are most common and fatal primary brain tumors. In addition to neoplastic cells, the tumor tissue contains microglial cells and…”
    Get full text
    Journal Article
  2. 2

    Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis by Afanasievа, O I, Pylaeva, E A, Klesareva, E A, Potekhina, A V, Provatorov, S I, Afanasieva, M I, Krasnikova, T L, Masenko, V P, Arefieva, T I, Pokrovsky, S N

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…To study the role of lipoprotein(a) [Lp(a)] as a potential autoantigen causing the activation of immunocompetent cells in atherosclerosis. A total of 104 men…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins) by Arefieva, T. I., Filatova, A. Yu, Potekhina, A. V., Shchinova, A. M.

    Published in Biochemistry (Moscow) (01-08-2018)
    “…Inhibitors of HMG-CoA reductase (statins) are the major group of lipid-lowering drugs. Along with hypocholesterolemic activity, statins exhibit…”
    Get full text
    Journal Article
  5. 5

    Immunoinflammatory Aspects of Parkinson’s Disease by Belova, O. V., Arefieva, T. I., Moskvina, S. N.

    Published in Neuroscience and behavioral physiology (01-11-2020)
    “…This review analyzes immunological impairments in Parkinson’s disease (PD). We present data on neuroinflammation, with which cell degeneration in the…”
    Get full text
    Journal Article
  6. 6

    Biodegradable Microparticles with Encapsulated Anti-Inflammatory Peptide Ingramon by Marmiy, N. V., Arefieva, T. I., Esipov, D. S., Tashlitsky, V. N., Kozhokar, U. S., Ovchinnikov, M. V., Radyukhina, N. V., Sidorova, M. V.

    Published in Pharmaceutical chemistry journal (01-11-2023)
    “…A technique for encapsulating the anti-inflammatory dodecapeptide ingramon into microspheres of a biodegradable copolymer of lactic and glycolic acids (PLGA)…”
    Get full text
    Journal Article
  7. 7

    The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction by Ovchinnikov, A G, Arefieva, T I, Potekhina, A V, Filatova, A Yu, Ageev, F T, Boytsov, S A

    Published in Actanaturae (01-04-2020)
    “…Heart failure with preserved ejection fraction (HFpEF) is a severe disease with an often unfavorable outcome. The prevalence of HFpEF continues to increase,…”
    Get full text
    Journal Article
  8. 8

    Expression of Markers of Regulatory CD4⁺CD25⁺foxp3⁺ Cells in Atherosclerotic Plaques of Human Coronary Arteries by Sokolov, V. O, Krasnikova, T. L, Prokofieva, L. V, Kukhtina, N. B, Arefieva, T. I

    “…The content of marker foxp3 of regulatory T cells and chemokines in atherosclerotic plaques of human coronary arteries was measured by the polymerase chain…”
    Get full text
    Journal Article
  9. 9

    Lipoprotein(a) concentration and the blood content of INFγ-producing T-helpers 17 (Th17/1) in males with premature coronary artery disease by Filatova, A. Yu, Afanasieva, O. I., Arefieva, T. I., Klesareva, E. A., Tyurina, A. V., Ezhov, M. V., Pokrovsky, S. N.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-07-2022)
    “…Aim . To analyze the relationship of blood lipid profile parameters, including the level of lipoprotein(a) (Lp(a)), and the content of circulating CD4+…”
    Get full text
    Journal Article
  10. 10

    Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis by Filatova, A. Yu, Arefieva, T. I., Klesareva, E. A., Afanasieva, O. I.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (14-06-2019)
    “…Statins are currently the main group of lipid-lowering drugs used in clinical practice. However not all patients manage to achieve ‘target’ levels of LDL. A…”
    Get full text
    Journal Article
  11. 11
  12. 12

    THE INFLUENCE OF ATORVASTATIN AND ROSUVASTATIN IN ATHEROSCLEROSIS ON THE PARAMETERS OF CELLULAR IMMUNITY AND IN VITRO LEUCOCYTE ACTIVATION by Filatova, A. Yu, Potekhina, A. V., Ruleva, N. Yu, Radyukhina, N. V., Arefieva, T. I.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (09-09-2018)
    “…Aim. To compare the influence of “lipophilic” atorvastatin and “hydrophilic” rosuvastatin on the parameters of cellular immunity in atherosclerosis patients…”
    Get full text
    Journal Article
  13. 13

    Cysteine-Containing Peptides Stimulate Monocyte Migration through NADPH-Oxidase Activation by Krasnikova, T. L., Arefieva, T. I., Pylaeva, E. A., Sidorova, M. V.

    “…We analyzed migration of monocytes under the effect of apocinin (NADPH inhibitor) and PD98059 (blocker of extracellular MEK/ERK kinase involved in Nox4…”
    Get full text
    Journal Article
  14. 14

    The severity of internal carotid artery stenosis is associated with the circulating Th17 level by Filatova, A.Yu, Potekhina, A.V., Pylaeva, E.A., Osokina, A.K., Ruleva, N.Yu, Pogorelova, O.A., Tripoten, M.I., Noeva, E.A., Balakhonova, T.V., Masenko, V.P., Arefieva, T.I.

    Published in Heliyon (01-05-2020)
    “…Immune and inflammatory reactions contribute to the progression of atherosclerosis. The walls of the different arteries and segments of the arteries have…”
    Get full text
    Journal Article
  15. 15

    Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris by Filatova, A Y, Osokina, A K, Potekhina, A V, Romasov, I V, Kotkina, T I, Shchinova, A M, Noeva, E A, Arefieva, T I, Barabanova, E A, Merkulov, E V, Samko, A N, Provatorov, S I

    Published in Terapevtic̆eskii arhiv (10-01-2021)
    “…Coronary stenting is the evidence-based treatment approach of stable angina. The objective was to determine the incidence of restenosis or atherosclerosis…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Intracellular signal cascade in CD4+ T-lymphocyte migration stimulated by interferon-gamma-inducible protein-10 by Kukhtina, N B, Arefieva, T I, Krasnikova, T L

    Published in Biochemistry (Moscow) (01-06-2005)
    “…The intracellular signal cascades involved in chemokine-stimulated migration of in vitro activated human peripheral blood CD4+ T-lymphocytes were investigated…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Subpopulation Composition of CD4+ T-lymphocytes as Factor Contributing to the Progression of Atherosclerosis of Carotid Arteries by Filatova, A Yu, Pylaeva, E A, Potekhina, A V, Osokina, A K, Pogorelova, O A, Tripoten, M I, Balakhonova, T V, Provatorov, S I, Noeva, E A, Klesareva, E A, Afanasieva, O I, Arefieva, T I

    Published in Kardiologiia (01-04-2017)
    “…to assess prognostic significance of blood content of regulatory and effector T-lymphocytes for progression of atherosclerosis (AS) of carotid arteries. We…”
    Get more information
    Journal Article
  20. 20